| Literature DB >> 35846384 |
Waseem Ahmed1, Rafia Azmat2, Nabila Chendouh-Brahmi3, Rasheed Ahmed4, Saima Naz5, Abdul Qayyum6, Ahmad El Askary7, Amal F Gharib7, Amani A Alrehaili7, Nausad Ali8.
Abstract
Antibacterial drug-resistant strains are a serious problem of bacterial treatments nowadays and have a concern. The plant exacts of Adhatoda vasica and Calotropis procera are well-known for their role as antibiotic agents. The extraction of novel antibiotic compounds was done by HPLC-DAD, their yield is quantified by numerous solvents. The complete biological activity with antioxidants, bio-kinematicof four compounds of B-Sitosteryl linoleate, Myristyl diglucoside, D-Triglucopyranoside, and S- allylcysteine acids were studied. The supercritical fluid extraction techniques were the best strategies for higher yield, accuracy clarity, and inter, intra process of all four compounds. A. vasica and C. procera samples and investigated in six different solvents. D-Triglucopyranoside (13.81 ± 0.48%), Myristyl diglucoside (11.81 ± 0.41%), B- Sitosteryl linoleate (12.81 ± 0.48%), and s-allylcysteine acids (14.81 ± 0.31%) were higher. The design and action of compounds were applied to proper compartmental pharmacokinetic modelling for in-depth design understanding. The morphology and structure of bacterial cells with the extracted compounds upheld the permeability of cell membranes, membrane integrity, and membrane potential and lower the bacterial binding capacity the infectious index was measured in transmission electron microscopy (TEM) and their alteration process. Plants have well upheld the cellular permeability The toxicity test was performed on both extracted samples with concentrations (1, 0.4, and 0.8%). The areas under plasma half-life of compounds with their solubility, abortion level were higher in four compounds showed the potential of novel antibiotics. The novel medicinal plants used as antibiotics could be the best sources of infection control as a source of future medicines with antibacterial potential solving multidrug issues of bacteria in the world.Entities:
Keywords: Antibacterial resistant; Compartment; Cytotoxicity; Herbal; Medicines; Pharmacokinetics
Year: 2022 PMID: 35846384 PMCID: PMC9283668 DOI: 10.1016/j.sjbs.2022.103351
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
Solvent based efficiency of B-Sitosteryl linoleate, Myristyl diglucoside, D-Triglucopyranoside, Sallylcysteine acid from Adhatoda vasica and Calotropis procera as novel compounds.
| Novel antibiotic compounds | (%) | ||||
|---|---|---|---|---|---|
| Herbal leave extracts | Several Extraction solvents | linoleate | diglucoside | Triglucopyranoside | Sitostery linoleate |
| Adhatoda vasica | Methanol | 12.81 ± 0.48 | 11.81 ± 0.41 | 13.81 ± 0.48 | 14.81 ± 0.31 |
| Ethyl acetate | 8.11 ± 0.17 | 7.11 ± 0.16 | 9.11 ± 0.11 | 7.11 ± 0.14 | |
| Chloroform | 9.72 ± 0.06 | 8.72 ± 0.05 | 8.72 ± 0.04 | 7.71 ± 0.03 | |
| Hexane | 7.1 ± 0.02 | 6.92 ± 0.01 | 6.2 ± 0.02 | 6.91 ± 0.01 | |
| Aqueous | 6.91 ± 0.03 | 5.90 ± 0.02 | 5.81 ± 0.03 | 5.90 ± 0.02 | |
| Ascorbic acid | 5.91 ± 0.04 | 4.99 ± 0.02 | 3.92 ± 0.04 | 2.99 ± 0.02 | |
| Calotropis procera | Methanol | 13.81 ± 0.46 | 13.81 ± 0.41 | 12.81 ± 0.46 | 11.81 ± 0.41 |
| Ethyl acetate | 9.11 ± 0.15 | 8.11 ± 0.16 | 9.11 ± 0.15 | 8.11 ± 0.16 | |
| Chloroform | 8.71 ± 0.05 | 7.72 ± 0.05 | 8.71 ± 0.05 | 7.72 ± 0.05 | |
| Hexane | 6.1 ± 0.03 | 6.96 ± 0.01 | 6.1 ± 0.03 | 6.90 ± 0.01 | |
| Aqueous | 5.91 ± 0.02 | 5.96 ± 0.03 | 5.92 ± 0.02 | 5.91 ± 0.03 | |
| Ascorbic acid | 4.91 ± 0.03 | 4.92 ± 0.02 | 13.81 ± 0.48 | 14.81 ± 0.31 |
Mean of three determinations with ± SD of medical plants.
Fig. 1The medicinal plants as novel compounds.
Fig. 2HPLC-DAD/MS/ chromatograph of compounds peaks indicated as follows: (1) B-Sitosteryl linoleate (2) Myristyl diglucoside (3) 2 D-Triglucopyranoside (4) S-allylcysteine acid A (Adhatoda vasica) and B (Calotropis procera).
Fig. 3Chemo-fingerprinting chromatograms confirmation of with numerical A (Adhatoda vasica) and B (Calotropis procera) as follows follows (1) B-Sitosteryl linoleate (2) Myristyl diglucoside (3) 2 D-Triglucopyranoside (4) S-allylcysteineacid.
Methods extraction of B-Sitosteryl linoleate and Myristyl diglucoside D-Triglucopyranoside allylcysteine acid from Adhatoda vasica and Calotropis procera.
| Herbal Extracts | Extraction methods | B-Sitosteryl linoleate, | Myristyl diglucoside | D-Triglucopyranoside | S-allylcysteine acid |
|---|---|---|---|---|---|
| Cold extraction (CE) | 11.81 ± 0.48 | 11.81 ± 0.41 | 12.81 ± 0.48 | 11.81 ± 0.41 | |
| Super critical Fluid extraction (SCFE) | 12.11 ± 0.17 | 12.11 ± 0.11 | 18.11 ± 0.17 | 17.11 ± 0.16 | |
| Microwave assisted extraction (MAE) | 9.72 ± 0.06 | 8.72 ± 0.01 | 9.72 ± 0.06 | 8.72 ± 0.05 | |
| Exhaustive extraction (EE | 7.1 ± 0.02 | 6.92 ± 0.01 | 7.1 ± 0.02 | 6.92 ± 0.01 | |
| Liquid-liquid micro- extraction (LLME) | 6.91 ± 0.03 | 5.90 ± 0.02 | 6.91 ± 0.03 | 5.90 ± 0.02 | |
| Cold extraction (CE) | 13.81 ± 0.46 | 13.81 ± 0.41 | 13.81 ± 0.46 | 13.81 ± 0.41 | |
| Super critical Fluid extraction (SCFE) | 9.11 ± 0.15 | 8.11 ± 0.16 | 9.11 ± 0.15 | 8.11 ± 0.16 | |
| Microwave assisted extraction (MAE) | 8.71 ± 0.05 | 7.72 ± 0.05 | 8.71 ± 0.05 | 7.72 ± 0.05 | |
| Exhaustive extraction (EE | 6.1 ± 0.03 | 6.96 ± 0.01 | 6.1 ± 0.03 | 6.96 ± 0.01 | |
| Liquid-liquid micro- extraction (LLME) | 5.91 ± 0.02 | 5.96 ± 0.03 | 15.91 ± 0.02 | 14.96 ± 0.03 |
Means of three determinations ± SD of species.
Accuracy and validations of compounds data of chromatographic separation via HPLC-DAD methods.
| Antibiotic Bioactive Compounds | tR (min) a | b (nm)b | LOD: detection limit c | LOQ: quantification limit d | Linear range (mol/l) | (r)a | Intraday (RSD%)b | Interday (CV%) c | Accuracy (%) |
|---|---|---|---|---|---|---|---|---|---|
| B-Sitosteryl linoleate, | 4.11 | 280 | 0.8 | 1.2 | 0.19-9.25 | 0.967 | 0.6 | 1.12 | 101.1 |
| Myristyl diglucoside | 10.13 | 280 | 0.9 | 0.5 | 0.22-10.11 | 0.968 | 0.8 | 0.24 | 102.2 |
| D-Triglucopyranoside | 7.11 | 280 | 1.0 | 0.8 | 0.23-10.75 | 0.988 | 0.7 | 1.25 | 98.4 |
| S-allylcysteine acid | 15.14 | 280 | 1.3 | 0.9 | 0.21-17.51 | 0.962 | 0.9 | 0.98 | 94.3 |
General LOD = 1.22, General LOQ = 1.23 a tR: retention time, b: wavelength, c LOD: detection, limit, d LOQ: quantification limit, a correlation coefficient, b RSD: relative standard deviation, c CV: coefficient of variation.
Stability Precision, Analysis of recovery of compounds by (HPLC- DAD) methods.
| Antibiotic Bioactive Compounds | Original in mg | Detection (mg) | Addition (mg) | RSD a (%) | RPA | RRT | Recovery b (%) |
|---|---|---|---|---|---|---|---|
| B-Sitosteryl linoleate | 4.12 | 4.101 | 1.12 | 0.121 | 4.12 ± 0.512 | 4.12 ± 0.512 | 100.1 |
| Myristyl diglucoside | 10.11 | 10.11 | 1.25 | 0.123 | 4.12 ± 0.512 | 4.11 ± 0.01 | 101.2 |
| D-Triglucopyranoside | 7.11 | 7.21 | 1.23 | 0.551 | 10.12 ± 0.513 | 10.13 ± 0.02 | 99.1 |
| S-allylcysteine acid | 15.10 | 15.11 | 0.12 | 0.121 | 7.12 ± 0.501 | 7.11 ± 0.01 | 98.1 |
The data was present as average of three trails. a RSD (%) = (SD of amount detected/mean of amount detected) × 100. b Recovery (%) = 100 × (amount detected – original amount)/addition retention area and relative retention time, SD is Presented as replicate of three trails.
Various methods of MBCs) minimum bacterial concentrations MIC minimum inhibition concentrations (CFICI) Combined fractional inhibitory concentration index of herbal extracts.
| Bacterial Strain | Various methods of antibacterial activity | |||||
|---|---|---|---|---|---|---|
| (MBCs) (μg/ml) | MIC(μg/ml) | (CFICI) (μg/ml) | ||||
| Gram positive bacteria | ||||||
| 520 | 432 | 521 | 433 | 515 | 432 | |
| 230 | 203 | 230 | 206 | 229 | 203 | |
| Gram negative bacteria | ||||||
| 335 | 331 | 338 | 333 | 333 | 330 | |
| 272 | 266 | 272 | 267 | 271 | 265 | |
| 150 | 100 | 150 | 104 | 333 | 330 | |
Fig. 5Fractional inhibitory concentration (FIC) for different bacterial strains Each vertical bar represents mean of three replicates ± S.E.
Fig. 6Altercation changes of bacterial responses of various antibiotic compounds, B-Sitostery Myristyld D-Triglucopyranoside S-allylcysteine A. vasica and in first figure are control reaming b-f five bacterial strains of C. procera by transmission electron microscopy (TEM).
Fig. 7a and b. Scanning and transmission electron microscope easements of infectious index changes in (a-d) of fours compounds and five bacterial cells one as control are used by liquid extracts of A. vasica and C. procera of transmission electron microscopy (TEM).
Antioxidants Activity FRAP, TAC, and ABTS assay of A. vasica & C. procera by different extractions solvents.
| Preparation of solvents | Several of Antioxdants | |||||
|---|---|---|---|---|---|---|
| Antioxidants Activity FRAP assay | Total antioxdants capacity (TAC) | Ferric reducing antioxidant power (ABTS) assay | ||||
| Methanol | 12.81 ± 0.40 | 13.81 ± 0.41 | 11.81 ± 0.41 | 13.81 ± 0.41 | 13.81 ± 0.41 | 13.81 ± 0.41 |
| Ethyl acetate | 12.11 ± 0.11 | 11.11 ± 0.12 | 12.11 ± 0.12 | 12.11 ± 0.12 | 11.11 ± 0.12 | 11.11 ± 0.12 |
| Chloroform | 11.71 ± 0.03 | 10.71 ± 0.02 | 11.71 ± 0.02 | 9.71 ± 0.02 | 10.71 ± 0.02 | 10.71 ± 0.02 |
| Hexane | 10.92 ± 0.01 | 9.92 ± 0.01 | 102 ± 0.01 | 8.92 ± 0.01 | 9.92 ± 0.01 | 9.92 ± 0.01 |
| Aqueous | 3.91 ± 0.02 | 1.91 ± 0.03 | 3.91 ± 0.03 | 2.91 ± 0.03 | 1.91 ± 0.03 | 1.91 ± 0.03 |
| Ascorbic acid | 2.91 ± 0.03 | 2.91 ± 0.01 | 2.91 ± 0.01 | 1.91 ± 0.01 | 2.91 ± 0.01 | 2.91 ± 0.01 |
Mean of three determinations of ± SD of herbal.
Response of liquid extracts on altercation of permeability of cell membrane of bacteria, integrity of cell membrane of bacteria at cell level.
| Bacterial strains | Adhatoda vasica Extracts Bacterial changes in cells | Calotropis procera Extracts Bacterial changes | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Permeability of cell membrane of bacteria | Integrity of cell membrane of bacteria | Membrane potential | Bacteria binding activity | Infectious index | Permeability of cell membrane of bacteria | Integrity of cell membrane of bacteria | Membrane potential | Bacteria binding binding | Infectious index | |
| 13.81 ± 0.40 | 11 0.81 ± 0.41 | 10.81 ± 0.40 | 6.81 ± 0.40 | 3.81 ± 0.40 | 12.81 ± 0.40 | 11 0.81 ± 0.41 | 10.81 ± 0.40 | 6.81 ± 0.40 | 2.81 ± 0.40 | |
| 11.11 ± 0.11 | 10.11 ± 0.12 | 13.11 ± 0.11 | 4.11 ± 0.11 | 4.11 ± 0.11 | 10.11 ± 0.11 | 10.11 ± 0.12 | 13.11 ± 0.11 | 4.11 ± 0.11 | 311 ± 0.11 | |
| 12.71 ± 0.03 | 11.71 ± 0.02 | 12.71 ± 0.03 | 3.71 ± 0.03 | 2.71 ± 0.03 | 11.71 ± 0.03 | 11.71 ± 0.02 | 12.71 ± 0.03 | 3.71 ± 0.03 | 1.71 ± 0.03 | |
| 14.92 ± 0.01 | 9.92 ± 0.01 | 11.92 ± 0.01 | 8.92 ± 0.01 | 4.92 ± 0.01 | 13.92 ± 0.01 | 9.92 ± 0.01 | 11.92 ± 0.01 | 8.92 ± 0.01 | 2.92 ± 0.01 | |
| 4.91 ± 0.02 | 2.91 ± 0.03 | 4.31 ± 0.02 | 2.91 ± 0.02 | 2.91 ± 0.02 | 3.91 ± 0.02 | 2.91 ± 0.03 | 4.31 ± 0.02 | 2.91 ± 0.02 | 2.91 ± 0.02 | |
Drugs formulations and compartment modelling in pharmacokinetic studies of chemicals for suitable 528 medicines.
| Antibiotic Bioactive compounds | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T max | AUC | Half life | T max | AUC | Half life | |||||||
| Mean | Range | Mean | Range | Mean | Range | Mean | Range | Mean | Range | Mean | Range | |
| B-Sitosteryl linoleate, | 0.7 | 0.8 | 0.1 | 0.2 | 1.1 | 1.2 | 0.5 | 0.9 | 0.1 | 0.2 | 1.1 | 2.2 |
| Myristyl diglucoside | 0.2 | 0.3 | – | – | 1.3 | 2.1 | 0.2 | 0.3 | – | – | 1.3 | 3.1 |
| D-Triglucopyranoside | 6.0 | 0.7 | – | – | 2.1 | 3.1 | 2.0 | 0.7 | – | – | 2.1 | 4.1 |
| S-allylcysteine Acid | 1.1 | 1.3 | 0.1 | 0.2 | – | – | 2.0 | 0.7 | – | – | 2.1 | 4.1 |
T max, total maximum AUC, area under plasma concentration, Half-life of compounds, Mean of three determinations ± SD of herbal plants compounds as used in medicines.
Fig. 8Drugs design of antibiotic compounds its changes.
Design and mode of action of compounds responses under Pharmacokinetics with bioability of compounds changes
| Antibiotic Bioactive | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acid dissociation constant (pKa) | Solubility | Absorption capacity | Acid dissociation constant (pKa) | Solubility | Absorption capacity | |||||||
| Mean | Range | Mean | Range | Mean | Range | Mean | Range | Mean | Range | Mean | Range | |
| B-Sitosteryl linoleate, | 0.9 | 0.9 | 0.2 | 0.2 | 2.1 | 1.2 | 0.5 | 0.9 | 0.1 | 0.2 | 2.1 | 2.2 |
| Myristyl diglucoside | 0.4 | 0.2 | 0.1 | – | 1.5 | 2.1 | 0.2 | 0.3 | 0.1 | – | 2.3 | 3.1 |
| D-Triglucopyranoside | 6.3 | 0.6 | – | – | 2.2 | 3.4 | 2.0 | 0.7 | – | 3.1 | 4.1 | |
| S-allylcysteine Acid | 2.1 | 1.4 | 2.1 | 0.2 | 2.1 | 3.1 | 2.0 | 0.7 | 2.1 | 0.2 | 2.1 | 4.7 |
Mean of three determinations ± SD of herbal plants compounds as used in medicines.
Fig. 9Drugs design of antibiotic compounds its changes.
Fig. 10Potential cytotoxicity level of two herbal species for controlling of toxins in different at Bacterial strains. Each vertical bar represents mean of three replications.
Fig. 11Lactate dehydrogenase (LD) activity assay from A. vasica and C.proce.